- Home
- PLUR vs ARTV Comparison
PLUR vs ARTV Comparison
Compare PLUR & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- ARTV
- Stock Information
- Founded
- PLUR 2001
- ARTV 2019
- Country
- PLUR Israel
- ARTV United States
- Employees
- PLUR N/A
- ARTV N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- ARTV
- Sector
- PLUR Health Care
- ARTV
- Exchange
- PLUR Nasdaq
- ARTV NYSE
- Market Cap
- PLUR 41.9M
- ARTV 39.0M
- IPO Year
- PLUR N/A
- ARTV 2024
- Fundamental
- Price
- PLUR $5.48
- ARTV $1.74
- Analyst Decision
- PLUR Strong Buy
- ARTV Strong Buy
- Analyst Count
- PLUR 1
- ARTV 8
- Target Price
- PLUR $12.00
- ARTV $18.14
- AVG Volume (30 Days)
- PLUR 62.5K
- ARTV 310.0K
- Earning Date
- PLUR 05-13-2025
- ARTV 08-28-2025
- Dividend Yield
- PLUR N/A
- ARTV N/A
- EPS Growth
- PLUR N/A
- ARTV N/A
- EPS
- PLUR N/A
- ARTV N/A
- Revenue
- PLUR $1,034,000.00
- ARTV N/A
- Revenue This Year
- PLUR $472.39
- ARTV N/A
- Revenue Next Year
- PLUR $254.29
- ARTV N/A
- P/E Ratio
- PLUR N/A
- ARTV N/A
- Revenue Growth
- PLUR 203.23
- ARTV N/A
- 52 Week Low
- PLUR $3.33
- ARTV $1.47
- 52 Week High
- PLUR $7.13
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- PLUR 59.69
- ARTV N/A
- Support Level
- PLUR $4.61
- ARTV N/A
- Resistance Level
- PLUR $5.96
- ARTV N/A
- Average True Range (ATR)
- PLUR 0.56
- ARTV 0.00
- MACD
- PLUR 0.11
- ARTV 0.00
- Stochastic Oscillator
- PLUR 77.03
- ARTV 0.00
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).